Offers Hope To
"These devices help those living with epilepsy whose seizures can’t be controlled with medications and who are not candidates for brain surgery."
— Marvin Rossi, MD, PhD
A device approved recently by the FDA has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with Rush’s innovative electrode placement planning system, the device helped eliminate seizures in nearly half of the Rush patients enrolled in clinical trials.